Esketamine (Spravato)
Esketamine (Spravato) is an FDA-approved nasal spray medication for treatment-resistant depression and major depressive disorder with suicidal ideation.
FDA Approved
Evidence-Based
Treatment Overview
Esketamine (Spravato) is an FDA-approved nasal spray medication for treatment-resistant depression and major depressive disorder with suicidal ideation. This comprehensive guide covers everything you need to know about Esketamine therapy, including effectiveness, treatment process, side effects, and costs.
Key Benefits
- • FDA-approved treatment option
- • Evidence-based therapy
- • Specialized for treatment-resistant cases
- • Professional medical supervision
Find Providers
Ready to explore Esketamine treatment?
Find Esketamine ClinicsTMS
Non-invasive brain stimulation therapy for depression
Learn MoreIM Ketamine
Injectable ketamine therapy for depression and chronic pain
Learn More